Navigation Links
China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference

China Biologic Products to Present at Brean Murray, Carret 2010 China Growth... -- TAI'AN, China, Nov. 15, 2010 /PRNewswire-Asia-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference


TAI'AN, China, Nov. 15, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management will present at the upcoming Brean Murray, Carret & Co. 2010 China Growth Conference. Date:

November 17, 2010 Time:

09:20 a.m. ESTPresenter:

Ming Yin, Vice President - Finance Location:

Track IIThe Millennium Broadway Hotel145 West 44th StreetNew York, New York 10036The Brean Murray, Carret & Co. 2010 China Growth Conference is a two-day conference (November 17-18, 2010) that consists of 25-minute presentation slots followed by 10-minutes of open floor Q&A sessions with institutional investors. Senior management of presenting companies, industry experts, and institutional investors will receive a unique and comprehensive view of China from a global perspective. China Biologic's management will be available for 1x1 meetings before and after the Company's presentation.

About China Biologic Products, Inc.China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biological Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently one of the leading plasma-based biopharmaceutical company in China. The Company is a fully integrated biological products company with plasma collection, production and manufacturing, research and development and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.

Company Contact:Mr. Ming YinVice President - FinanceChina Biologic Products, Inc.Tel: +86-851-3605846Email: Investor Relations Contact:Mr. Crocker Coulson, President CCG Investor RelationsPhone: +1 (646) 213-1915Email:

SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics Appoints New Chief Operating Officer
2. China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results
3. China-Biotics to Report Fiscal Year 2011 Second Quarter Financial Results on November 9
4. Verenium Announces Regulatory Approval for Purifine® PLC in China
5. China Cord Blood Corporation Files Its Annual Report on Form 20-F/A
6. Reportlinker Adds Industrial Biotechnology China News 1009
7. According to Opurity, Feds Put U.S. Consumers at Risk: PTO Bureaucrats Refuse to Approve Vitamin Companys China-Free Trademark
8. Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco
9. China Cord Blood Corporation Updates Status Regarding Share Repurchase Program
10. China Pharma Holdings, Inc. Successfully Completes Phase I Clinical Trials of New Anti-Drug-Resistance Antibiotic
11. China-Biotics Hosted its First Investor Day Event
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):